Baby gene therapy study offers hope for fatal muscle disease | The … – Berkshire Eagle
Berkshire Eagle |
Baby gene therapy study offers hope for fatal muscle disease | The …
Berkshire Eagle Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born … Baby gene therapy study offers hope for fatal muscle disease | St …StMaryNow.com |
Berkshire Eagle |
Baby gene therapy study offers hope for fatal muscle disease | The …
Berkshire Eagle Dr. Jerry Mendell of the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. Mendell led a small study of gene therapy in babies born … Baby gene therapy study offers hope for fatal muscle disease | St …StMaryNow.com |
|
This CRISPR Bioethicist Says We Worry Too Much About A Dystopian Future
Fast Company CRISPR, the gene-editing technique revolutionizing biological research, has been welcomed as much as it has been feared by the scientific community. For all the awe surrounding the modification of tomato crops, there’s the unease of the Woolly Mammoth … |
|
This CRISPR Bioethicist Says We Worry Too Much About A Dystopian Future
Fast Company CRISPR, the gene-editing technique revolutionizing biological research, has been welcomed as much as it has been feared by the scientific community. For all the awe surrounding the modification of tomato crops, there’s the unease of the Woolly Mammoth … |
USC Viterbi School of Engineering (press release) (blog) |
The Stem Cell of Radio
USC Viterbi School of Engineering (press release) (blog) “I once heard SDR described as ‘the stem cell of radio’ – I can’t think of a better comparison,” said Krishnamachari, a Ming Hsieh Faculty Fellow in Electrical Engineering. “Imagine a device that can operate as a cell phone, Wi-Fi device, or FM … |
Medscape |
Immunotherapy for Lung Cancers: First-Line and Beyond
Medscape I’m Dr Jack West from Swedish Cancer Institute in Seattle, Washington. Joining me today for Medscape Oncology Insights are two colleagues who are experts in immunotherapy for non-small cell lung cancer (NSCLC) and the whole field of thoracic oncology. |